Aethlon Medical (0A6R) Stock Statistics & Valuation Metrics
Total Valuation
Aethlon Medical has a market cap or net worth of EUR 7.81M. The enterprise value is -EUR 2.98M.
- Market Cap
- EUR 7.81M
- Enterprise Value
- -EUR 2.98M
Share Statistics
Aethlon Medical has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- ―
- Owned by Insiders
- 7.62%
- Owned by Institutions
- 1.03%
Financial Efficiency
Aethlon Medical’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -139.64%.
- Return on Equity (ROE)
- -1.46
- Return on Assets (ROA)
- -1.13
- Return on Invested Capital (ROIC)
- -139.64%
- Return on Capital Employed (ROCE)
- -1.49
- Revenue Per Employee
- 0
- Profits Per Employee
- -794.61K
- Employee Count
- 9
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Aethlon Medical is -0.46. Aethlon Medical’s PEG ratio is -0.00.
- PE Ratio
- -0.46
- PS Ratio
- 0.00
- PB Ratio
- 0.40
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Aethlon Medical had revenue of 0 and earned -7.15M in profits. Earnings per share was -10.61.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -7.29M
- Pretax Income
- -7.15M
- Net Income
- -7.15M
- EBITDA
- -6.81M
- Earnings Per Share (EPS)
- -10.61
Cash Flow
In the last 12 months, operating cash flow was -1.90B and capital expenditures -9.15M, giving a free cash flow of -1.91B billion.
- Operating Cash Flow
- -1.90B
- Free Cash Flow
- -1.91B
- Free Cash Flow per Share
- -4967.38
Dividends & Yields
Aethlon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -66693.45%
- Earnings Yield
- -331.50%
Important Dates
Aethlon Medical upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Aethlon Medical as a current ratio of 3.85, with Debt / Equity ratio of 6.89%
- Current Ratio
- 3.85
- Quick Ratio
- 3.85
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.69
- Interest Coverage Ratio
- -507.49
Taxes
In the past 12 months, Aethlon Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Aethlon Medical EV to EBITDA ratio is 0.26, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.26
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Aethlon Medical has EUR 4.93M in cash and marketable securities with EUR 367.61K in debt, giving a net cash position of EUR 4.57M billion.
- Cash & Marketable Securities
- EUR 4.93M
- Total Debt
- EUR 367.61K
- Net Cash
- EUR 4.57M
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- EUR 13.52
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Aethlon Medical is EUR 1.34, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 1.34
- Price Target Upside
- ―
- Analyst Consensus
- Neutral
- Analyst Count
- 2
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
